Results 11 to 20 of about 26,059 (187)
YAKUGAKU ZASSHI, 2003 AbstractFor Abstract see ChemInform Abstract in Full Text.
Joseph Heyse +2 more
+6 more sources
Pharmacoeconomics in Africa: needs, prospect and challenges
Journal of Pharmaceutical Policy and Practice, 2021 Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases ...
Temitope Ben-Ajepe +5 more
semanticscholar +1 more source
Scientific Reports, 2022 The purpose of this work was to review and synthesise the evidence on the comparative effectiveness of neutralising monoclonal antibody (nMAB) therapies in individuals exposed to or infected with SARS-CoV-2 and at high risk of developing severe COVID-19.
David McConnell +6 more
doaj +1 more source
Pharmacoeconomics of obesity in China: a scoping review
Expert review of pharmacoeconomics & outcomes research, 2021 Background: With the growing rate of obesity and associated chronic conditions in China, there is a need to assess the health and economic burdens of obesity and examine the effectiveness of pharmaceutical, medical, and comprehensive weight-loss ...
Zhuo Chen +6 more
semanticscholar +1 more source
Cost analysis of the use of botulinum toxin type A in Spain [PDF]
Farmacia Hospitalaria, 2014 Objective: To estimate treatment costs of blepharospasm, cervical dystonia(CD), upper limb spasticity (ULS) and spasticity in children withcerebral palsy (SCCP) with botulinum neurotoxin type A (BoNT-A) inSpain.
F. de Andrés-Nogales +5 more
doaj +1 more source
BMC Public Health, 2023 Background Non-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget impact of implementing NPIs on ...
Leyi Liang +4 more
doaj +1 more source
On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers
Frontiers in Public Health, 2020 We present an overview of the main methodological features and the goals of pharmacoeconomic models that are classified in three major categories: regression models, decision trees, and Markov models. In particular, we focus on Markov models and define a
A. Carta, C. Conversano
semanticscholar +1 more source
PHARMACOECONOMICS AS A TOOL TO ENHANCE EFFICENCY OF HEALTH CARE SERVICES
Ринкова економіка: сучасна теорія і практика управління, 2017 Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to health care systems and society. This article discusses the principles and methods of pharmacoeconomics and how they can be applied to clinical pharmacy ...
Denys Zakrytov, Navneet Kaur
doaj +1 more source
Knowledge, Attitude, and Practices of Moroccan Retail Pharmacists towards Veterinary Medicines
Advances in Pharmacological and Pharmaceutical Sciences, 2022 This is the first study conducted in Morocco to assess knowledge, attitude, and practices of retail pharmacists regarding veterinary medicines. It is a cross-sectional study.
Zeinab Snoussi, Samir Ahid
doaj +1 more source
Frontiers in Pharmacology, 2022 Objective: After Gemstone-302 was published in Lancet in January 2022, seven PD-(L)1 inhibitors launched or about to be launched in China, but there are no head-to-head RCTs reporting the comparative efficacy for squamous non-small cell lung cancer (sq ...
Mingye Zhao +8 more
doaj +1 more source